Branded Legacy (OTC.PK: BLEG), Inc., a leading BioTech holdings company, announced today the signed letter of intent to purchase Sycamore BioPharma, LLC, an established developer of plant based pharmaceuticals. The strategic move aligns with Branded Legacy’s commitment to expanding its portfolio in the biotech sector and further solidifies its position as a key player in the industry.
Read the full article: Branded Legacy, Inc. Strengthens Position in BioTech Industry with Letter of Intent to Purchase Sycamore BioPharma, LLC //
Source: https://www.prnewswire.com/news-releases/branded-legacy-inc-strengthens-position-in-biotech-industry-with-letter-of-intent-to-purchase-sycamore-biopharma-llc-302075767.html